PolyPid Ltd
NASDAQ:PYPD

Watchlist Manager
PolyPid Ltd Logo
PolyPid Ltd
NASDAQ:PYPD
Watchlist
Price: 3.97 USD 1.28% Market Closed
Market Cap: 62.1m USD

Net Margin
PolyPid Ltd

0%
Current
0%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-34.2m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

PolyPid Ltd
Glance View

Market Cap
66m USD
Industry
Pharmaceuticals

PolyPid Ltd. is a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes. The firm focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.

PYPD Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-34.2m
/
Revenue
0
What is the Net Margin of PolyPid Ltd?

Based on PolyPid Ltd's most recent financial statements, the company has Net Margin of 0%.

Back to Top